L-305-2023
Agreement ID
L-305-2023
Lead IC
NIDCR
Exclusivity
Nonexclusive
External Party
Shape Therapeutics Inc.
Fiscal Year
2023
Territory
US
Execution Date
Effective Date
Export Date